We utilized two distinct siRNAs, namely, si-1 and si-2, to downregulate HMGB1 expression in CRC cells, and we validated the knockdown efficacy via Western blotting analysis (Fig. 3A). This evidence concerns the gene HMGB1 and colorectal carcinoma.